PD-L1 is a ligand which binds to the PD1 receptor, an immune checkpoint receptor involved in tumor immune escape [237], and its overexpression is prognostic in lung cancer and increases cancer cell proliferation and chemoresistance [238,239]. The gene discussed is CD274; the disease is lung carcinoma.